Docket Room
HB 2545·PA·house

An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.

Reported by CommitteeFiled May 27, 2026
Sponsor: Melissa Shusterman (D)
Latest Action

Re-referred to Aging & Older Adult Services

Jun 24, 2026

Summary

The bill obligates health insurance policies issued or renewed in Pennsylvania after the law takes effect to include coverage for vaginal estrogen used to treat menopausal symptoms and prevent urinary tract infections. Coverage must encompass all FDA‑approved vaginal estrogen drugs and devices, though insurers may still apply standard medical‑necessity, cost‑sharing and utilization‑review rules. The goal is to improve access to a common therapy for women experiencing menopause.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 2545 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice